Prostate cancer
Top Cited Papers
Open Access
- 11 June 2015
- journal article
- review article
- Published by Elsevier BV in The Lancet
- Vol. 387 (10013), 70-82
- https://doi.org/10.1016/s0140-6736(14)61947-4
Abstract
No abstract availableThis publication has 144 references indexed in Scilit:
- Targeted Next-generation Sequencing of Advanced Prostate Cancer Identifies Potential Therapeutic Targets and Disease HeterogeneityEuropean Urology, 2013
- Overcoming mutation-based resistance to antiandrogens with rational drug designeLife, 2013
- Screening for prostate cancerEmergencias, 2013
- Abiraterone acetate for treatment of metastatic castration-resistant prostate cancer: final overall survival analysis of the COU-AA-301 randomised, double-blind, placebo-controlled phase 3 studyThe Lancet Oncology, 2012
- From sequence to molecular pathology, and a mechanism driving the neuroendocrine phenotype in prostate cancerThe Journal of Pathology, 2012
- Combined androgen deprivation therapy and radiation therapy for locally advanced prostate cancer: a randomised, phase 3 trialThe Lancet, 2012
- Reciprocal Feedback Regulation of PI3K and Androgen Receptor Signaling in PTEN-Deficient Prostate CancerCancer Cell, 2011
- Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind studyThe Lancet, 2011
- Integrative Genomic Profiling of Human Prostate CancerCancer Cell, 2010
- Nuclear Receptor-Induced Chromosomal Proximity and DNA Breaks Underlie Specific Translocations in CancerCell, 2009